This in effect indicates that LDLR-expressing tumour cells within close proximity to the blood vessels as shown in our results, are potentially more susceptible to efficacious therapeutic targeting using LDL-mimicking stealth nanoparticles. This evidence concerns the gene LDLR and neoplasm.